ML-336 |
A quinazolinone-based compound that has been shown to inhibit a VEEV-induc… |
5 mg |
9001920-5 |
More Info
|
ML-345 |
A selective IDE inhibitor that selectively targets cysteine819 in IDE with… |
1 mg |
17633-1 |
More Info
|
ML-345 |
A selective IDE inhibitor that selectively targets cysteine819 in IDE with… |
10 mg |
17633-10 |
More Info
|
ML-345 |
A selective IDE inhibitor that selectively targets cysteine819 in IDE with… |
5 mg |
17633-5 |
More Info
|
ML-346 |
An activator of the heat shock response; induces the expression of HSP70,… |
1 mg |
23844-1 |
More Info
|
ML-346 |
An activator of the heat shock response; induces the expression of HSP70,… |
10 mg |
23844-10 |
More Info
|
ML-346 |
An activator of the heat shock response; induces the expression of HSP70,… |
25 mg |
23844-25 |
More Info
|
ML-346 |
An activator of the heat shock response; induces the expression of HSP70,… |
5 mg |
23844-5 |
More Info
|
ML-347 |
Selectively inhibits ALK1 (IC50 = 46 nM) and ALK2 (IC50 = 32 nM) with >300… |
1 mg |
17640-1 |
More Info
|
ML-347 |
Selectively inhibits ALK1 (IC50 = 46 nM) and ALK2 (IC50 = 32 nM) with >300… |
10 mg |
17640-10 |
More Info
|
ML-347 |
Selectively inhibits ALK1 (IC50 = 46 nM) and ALK2 (IC50 = 32 nM) with >300… |
5 mg |
17640-5 |
More Info
|
ML-347 |
Selectively inhibits ALK1 (IC50 = 46 nM) and ALK2 (IC50 = 32 nM) with >300… |
50 mg |
17640-50 |
More Info
|
ML-348 |
A selective, reversible LYPLA1 inhibitor (IC50 = 210 nM) |
1 mg |
18523-1 |
More Info
|
ML-348 |
A selective, reversible LYPLA1 inhibitor (IC50 = 210 nM) |
10 mg |
18523-10 |
More Info
|
ML-348 |
A selective, reversible LYPLA1 inhibitor (IC50 = 210 nM) |
25 mg |
18523-25 |
More Info
|
ML-348 |
A selective, reversible LYPLA1 inhibitor (IC50 = 210 nM) |
5 mg |
18523-5 |
More Info
|
ML-349 |
A selective and reversible inhibitor of LYPLA2 (Kis = 230 and >10,000 nM f… |
1 mg |
20923-1 |
More Info
|
ML-349 |
A selective and reversible inhibitor of LYPLA2 (Kis = 230 and >10,000 nM f… |
10 mg |
20923-10 |
More Info
|
ML-349 |
A selective and reversible inhibitor of LYPLA2 (Kis = 230 and >10,000 nM f… |
5 mg |
20923-5 |
More Info
|
ML-351 |
An inhibitor of human reticulocyte 15-LO-1 (IC50 = 200 nM) with >250-fold… |
1 mg |
16119-1 |
More Info
|
ML-351 |
An inhibitor of human reticulocyte 15-LO-1 (IC50 = 200 nM) with >250-fold… |
10 mg |
16119-10 |
More Info
|
ML-351 |
An inhibitor of human reticulocyte 15-LO-1 (IC50 = 200 nM) with >250-fold… |
25 mg |
16119-25 |
More Info
|
ML-351 |
An inhibitor of human reticulocyte 15-LO-1 (IC50 = 200 nM) with >250-fold… |
5 mg |
16119-5 |
More Info
|
ML-352 |
An inhibitor of the presynaptic choline transporter (Kis = 92 and 166 nM f… |
1 mg |
21878-1 |
More Info
|
ML-352 |
An inhibitor of the presynaptic choline transporter (Kis = 92 and 166 nM f… |
10 mg |
21878-10 |
More Info
|
ML-352 |
An inhibitor of the presynaptic choline transporter (Kis = 92 and 166 nM f… |
5 mg |
21878-5 |
More Info
|
ML-354 |
A PAR4 antagonist (IC50 = 140 nM) that exhibits 71-fold selectivity for PA… |
1 mg |
19120-1 |
More Info
|
ML-354 |
A PAR4 antagonist (IC50 = 140 nM) that exhibits 71-fold selectivity for PA… |
10 mg |
19120-10 |
More Info
|
ML-354 |
A PAR4 antagonist (IC50 = 140 nM) that exhibits 71-fold selectivity for PA… |
25 mg |
19120-25 |
More Info
|
ML-354 |
A PAR4 antagonist (IC50 = 140 nM) that exhibits 71-fold selectivity for PA… |
5 mg |
19120-5 |
More Info
|
ML-355 |
A selective inhibitor of 12-LO (IC50 = 0.34 µM) with greatly reduced… |
1 mg |
18537-1 |
More Info
|
ML-355 |
A selective inhibitor of 12-LO (IC50 = 0.34 µM) with greatly reduced… |
10 mg |
18537-10 |
More Info
|
ML-355 |
A selective inhibitor of 12-LO (IC50 = 0.34 µM) with greatly reduced… |
25 mg |
18537-25 |
More Info
|
ML-355 |
A selective inhibitor of 12-LO (IC50 = 0.34 µM) with greatly reduced… |
5 mg |
18537-5 |
More Info
|
ML-356 |
A selective inhibitor of FASN-TE (IC50 = 334 nM); blocks the biosynthesis… |
1 mg |
20940-1 |
More Info
|
ML-356 |
A selective inhibitor of FASN-TE (IC50 = 334 nM); blocks the biosynthesis… |
10 mg |
20940-10 |
More Info
|
ML-356 |
A selective inhibitor of FASN-TE (IC50 = 334 nM); blocks the biosynthesis… |
5 mg |
20940-5 |
More Info
|
ML-364 |
An inhibitor of USP2 (IC50 = 1.1 µM); inhibits the closely related U… |
1 mg |
21774-1 |
More Info
|
ML-364 |
An inhibitor of USP2 (IC50 = 1.1 µM); inhibits the closely related U… |
10 mg |
21774-10 |
More Info
|
ML-364 |
An inhibitor of USP2 (IC50 = 1.1 µM); inhibits the closely related U… |
25 mg |
21774-25 |
More Info
|
ML-364 |
An inhibitor of USP2 (IC50 = 1.1 µM); inhibits the closely related U… |
5 mg |
21774-5 |
More Info
|
ML-365 |
A TASK-1 potassium channel blocker (IC50 = 16 nM); selective for TASK-1 ov… |
1 mg |
24666-1 |
More Info
|
ML-365 |
A TASK-1 potassium channel blocker (IC50 = 16 nM); selective for TASK-1 ov… |
10 mg |
24666-10 |
More Info
|
ML-365 |
A TASK-1 potassium channel blocker (IC50 = 16 nM); selective for TASK-1 ov… |
25 mg |
24666-25 |
More Info
|
ML-365 |
A TASK-1 potassium channel blocker (IC50 = 16 nM); selective for TASK-1 ov… |
5 mg |
24666-5 |
More Info
|
ML-382 |
An MRGPRX1 positive allosteric modulator; potentiates BAM 22P (8-22)-induc… |
10 mg |
36668-10 |
More Info
|
ML-382 |
An MRGPRX1 positive allosteric modulator; potentiates BAM 22P (8-22)-induc… |
25 mg |
36668-25 |
More Info
|
ML-382 |
An MRGPRX1 positive allosteric modulator; potentiates BAM 22P (8-22)-induc… |
5 mg |
36668-5 |
More Info
|
ML-382 |
An MRGPRX1 positive allosteric modulator; potentiates BAM 22P (8-22)-induc… |
50 mg |
36668-50 |
More Info
|
ML-385 |
An inhibitor of Nrf2 (IC50 = 1.9 µM) that blocks downstream target g… |
10 mg |
21114-10 |
More Info
|